Dr. Garyfalia Karponi
MICRODIAGNOSTICS S.A. is very pleased to announce its participation in the molecular profiling programme for patients with endometrial cancer of the Hellenic Society of Medical Oncology (HeSMO).
Patients with endometrial cancer who meet specific clinical criteria may be included in the programme.
The programme includes the performance of molecular tests that help with the classification and prognosis of the disease, as well as with the application of the most appropriate, personalized treatment regimen, based on the latest guidelines.
The cost of participation in the programme for eligible patients is covered by HeSMO, thus filling a gap left by the state, as molecular tests for most solid tumors remain non-reimbursed.
For more information regarding the inclusion criteria, please visit the HeSMO website.
We warmly thank the Hellenic Society of Medical Oncology for this initiative.
Garyfalia Karponi, MSc, PhD
Molecular Biologist-Geneticist
Chief Scientific Officer, Department of Molecular Diagnostics